Effects of High Dose Ribavirin, Alinia® (Nitazoxanide) and Pegylated Interferon alfa-2a in Attaining Sustained Viral Response in Treatment of Chronic Hepatitis C (ERAIS-C trial) - Interim Results in Naive Genotype 1 Patients

被引：1
|
作者：
Basu, P. Patrick [1 ]
Rayapudi, Krishna [2 ]
Pacana, Tommy [2 ]
Shah, Niraj James [2 ]
Brown, Robert [1 ]
机构：
[1] Columbia Univ, Coll Phys & Surg, New York, NY USA
[2] Forest Hills Hosp, Forest Hills, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷
关键词：
D O I：
10.14309/00000434-200910003-00330
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
330
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF HIGH DOSE RIBAVIRIN (RBV), ALINIA (NITAZOXANIDE) AND PEGYLATED INTERFERON (PEG) ALFA-2A IN ATTAINING SUSTAINED VIRAL RESPONSE (SVR) IN TREATMENT OF CHRONIC HEPATITIS C (ERAIS-C TRIAL) - INTERIM RESULTS IN NAiVE GENOTYPE 1 PATIENTS
    Basu, P. Patrick
    Rayapudi, Krishna
    Shah, Niraj James
    Pacana, Tommy
    Brown, Robert S.
    HEPATOLOGY, 2009, 50 (04) : 730A - 731A
  • [2] Effect of high-dose ribavirin (RBV), Alinia (Nitazoxanide) and pegylated interferon (PegIFN) alfa-2a in attaining sustained virologic response (SVR) in treatment of chronic hepatitis C (ERAIS-C Trial) in naive genotype 1 patients
    Basu, P. P.
    Rayapudi, K.
    Pacana, T.
    Shah, N. J.
    Krishnaswamy, N.
    Hampole, H.
    Tang, C.
    Brown, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S1 - S2
  • [3] Effect of High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (pegIFN) Alfa-2a in Attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naive Genotype 1 Patients
    Basu, P. Patrick
    Rayapudi, Krishna
    Pacana, Tommy
    Shah, Niraj James
    Krishnaswamy, Nithya
    Brown, Robert S.
    GASTROENTEROLOGY, 2010, 138 (05) : S218 - S218
  • [4] EFFECT OF HIGH-DOSE RIBAVIRIN (RBV), ALINIA (NITAZOXANIDE) AND PEGYLATED INTERFERON (PEGIFN) ALFA-2A IN ATTAINING SUSTAINED VIROLOGIC RESPONSE (SVR) IN TREATMENT OF CHRONIC HEPATITIS C
    Basu, P.
    Rayapudi, K.
    Shah, N. J.
    Pacana, T.
    Krishnaswamy, N.
    Brown, R., Jr.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S102 - S102
  • [5] Response to Pegylated Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 4
    El Makhzangy, Hesham
    Esmat, Gamal
    Said, Mohamed
    ElRaziky, Maissa
    Shouman, Soheir
    Refai, Rasha
    Rekacewicz, Claire
    Gad, Rita Raafat
    Vignier, Nicolas
    Abdel-Hamid, Mohamed
    Zalata, Khaled
    Bedossa, Pierre
    Pol, Stanislas
    Fontanet, Arnaud
    Mohamed, Mostafa K.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) : 1576 - 1583
  • [6] Pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a or alfa-2b with ribavirin in treatment naive patients with genotype 1 chronic hepatitis C
    Di Bisceglie, AM
    Rustgi, VK
    Thuluvath, P
    Davis, M
    Ghalib, R
    Lyons, MF
    Ondovik, MS
    Lopez-Talavera, JC
    HEPATOLOGY, 2004, 40 (04) : 734A - 734A
  • [7] Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6
    Pham, Thuy T.
    Ho, Dat T.
    GASTROENTEROLOGY, 2009, 136 (05) : A840 - A840
  • [8] Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin
    Bronowicki, Jean-Pierre
    Ouzan, Denis
    Asselah, Tarik
    Desmorat, Herve
    Zarski, Jean-Pierre
    Foucher, Juliette
    Bourliere, Marc
    Renou, Christophe
    Tran, Albert
    Melin, Pascal
    Hezode, Christophe
    Chevalier, Michelle
    Bouvier-Alias, Magali
    Chevaliez, Stephane
    Montestruc, Francois
    Lonjon-Domanec, Isabelle
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2006, 131 (04) : 1040 - 1048
  • [9] Treatment of chronic hepatitis C with pegylated interferon alfa-2a plus ribavirin in hemophiliac patients
    Malekzadeh, R
    Merat, S
    Sohrabpour, AA
    Khaleghi, S
    Samimi-Rad, K
    GASTROENTEROLOGY, 2004, 126 (04) : A431 - A431
  • [10] Extrahepatic Manifestations of Chronic Hepatitis C and their Influence on Response to Treatment with Pegylated Interferon Alfa-2a and Ribavirin
    Fabri, Milotka
    Ruzic, Maja
    Lendak, Dajana
    Preveden, Tomislav
    Fabri, Izabella
    Petric, Vedrana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (5-6) : 320 - 324
12345